Grail (GRAL) Other Accumulated Expenses (2023 - 2026)
Grail's (GRAL) quarterly Other Accumulated Expenses came in at $1.1 million in Q2 2026, down 38.34% on a YoY basis from $1.8 million in Q2 2025, and down 39.62% quarter-over-quarter from $1.8 million in Q1 2026.
Analysis
Grail (GRAL) Other Accumulated Expenses (2023 - 2026) Analysis & Trends
Grail (GRAL) has reported Other Accumulated Expenses for 4 consecutive years, with $1.1 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Other Accumulated Expenses fell 38.34% year-over-year to $1.1 million; the trailing twelve-month figure through Jun 2026 stood at $1.1 million (down 38.34% YoY), and the FY2025 full-year result was $1.9 million, up 21.96% from the prior year.
- Other Accumulated Expenses fell to $1.1 million in Q2 2026 per GRAL's latest filing, from $1.8 million in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $2.5 million in Q1 2025 and bottomed at $809000.0 in Q4 2023.
- Historically, Other Accumulated Expenses has averaged $1.7 million across 4 years, with a median of $1.7 million in 2024.
- The sharpest annual moves came in 2024 and 2026: Other Accumulated Expenses jumped 95.3% in 2024, then slumped 38.34% in 2026.
- Over 4 years, Other Accumulated Expenses stood at $809000.0 in 2023, then surged by 95.3% to $1.6 million in 2024, then climbed by 21.96% to $1.9 million in 2025, then slumped by 42.5% to $1.1 million in 2026.
- According to Business Quant data, Other Accumulated Expenses over the past three periods registered $1.1 million, $1.8 million, and $1.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn |
| 10 | Grail | 3.61 Bn | 2.75 Bn | 21.34 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.11 Mn |
| Mar 31, 2026 | 1.84 Mn |
| Dec 31, 2025 | 1.93 Mn |
| Sep 30, 2025 | 1.93 Mn |
| Jun 30, 2025 | 1.80 Mn |
| Mar 31, 2025 | 2.51 Mn |
| Dec 31, 2024 | 1.58 Mn |
| Sep 30, 2024 | 1.59 Mn |
| Jun 30, 2024 | 1.41 Mn |
| Dec 31, 2023 | 809,000.00 |